P1074 (DAIDS ID 10660): A Prospective Surveillance Study of Long Term Outcomes in HIV-Infected Infants, Children and Adolescents

Study Status Study Restriction

Closed to Follow Up

United States

What is P1074?

P1074 (the IMPAACT Long-Term Follow-up (LTFU) study is a prospective surveillance study of long-term outcomes in infants, children, and adolescents with HIV infection.  The study is designed to identify long-term adverse outcomes of HIV infection and complications of antiretroviral therapy or experimental interventions other than antiretroviral therapy in participants at IMPAACT sites in the United States.

Study Documents:

P1074 Protocol V1 - 02 Feb 2009

P1074 V1 CM1 - 01 Jul 2011

P1074 CM2 - 02 Feb 2012

For a copy of the 'Final P1074 Surveillance Report, dated November 2014', please send a request by e-mail to the IMPAACT P1074 Protocol Team at impaact.teamp1074@fstrf.org.

Sites where the study is implemented:

CRS ID Site Name City Country

3801

Texas Childrens Hosp. CRS

Houston

United States of America

4001

Chicago Children's CRS

Chicago

United States of America

4201

University of Miami Pediatric/Perinatal HIV/AIDS

Miami

United States of America

4601

UCSD Mother-Child-Adolescent HIV Program

San Diego

United States of America

5011

Boston Medical Center Pediatric HIV Program

Boston

United States of America

5013

Jacobi Medical Center Bronx

Bronx

United States of America

5017

Univ of Washington Children's Hospital Seattle

Seattle

United States of America

5031

San Juan City Hospital

San Juan

United States of America

5040

SUNY Stony Brook

Stony Brook

United States of America

5048

University of Southern California LA

Los Angeles

United States of America

5051

University of Florida Jacksonville

Jacksonville

United States of America

5052

University of Colorado Denver NICHD CRS

Aurora

United States of America

5055

South Florida CDTC Ft Lauderdale NICHD CRS

Fort Lauderdale

United States of America

5092

Johns Hopkins University, Baltimore

Baltimore

United States of America

5112

UCLA - David Geffen School of Medicine

Los Angeles

United States of America

5114

Bronx-Lebanon Hospital IMPAACT

Bronx

United States of America

6501

St. Jude/UTHSC CRS

Memphis

United States of America

6601

University of Puerto Rico Pediatric HIV/AIDS Research Program CRS

San Juan

United States of America

Study contacts:

Clinical Trials Specialist: Kathleen George

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.